These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 36861094
1. Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42. Medina JI, Cruz-Collazo A, Del Mar Maldonado M, Gascot TM, Borrero-Garcia LD, Cooke M, Kazanietz MG, O'Farril EH, Vlaar CP, Dharmawardhane S. Cancer Res Commun; 2022 Dec; 2(12):1711-1726. PubMed ID: 36861094 [Abstract] [Full Text] [Related]
2. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer. Humphries-Bickley T, Castillo-Pichardo L, Hernandez-O'Farrill E, Borrero-Garcia LD, Forestier-Roman I, Gerena Y, Blanco M, Rivera-Robles MJ, Rodriguez-Medina JR, Cubano LA, Vlaar CP, Dharmawardhane S. Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422 [Abstract] [Full Text] [Related]
3. Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models. Torres-Sanchez A, Rivera-Robles M, Castillo-Pichardo L, Martínez-Ferrer M, Dorta-Estremera SM, Dharmawardhane S. Front Oncol; 2023 May; 13():1152458. PubMed ID: 37397366 [Abstract] [Full Text] [Related]
4. Development of EHop-016: a small molecule inhibitor of Rac. Dharmawardhane S, Hernandez E, Vlaar C. Enzymes; 2013 May; 33 Pt A(Pt A):117-46. PubMed ID: 25033803 [Abstract] [Full Text] [Related]
5. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. Montalvo-Ortiz BL, Castillo-Pichardo L, Hernández E, Humphries-Bickley T, De la Mota-Peynado A, Cubano LA, Vlaar CP, Dharmawardhane S. J Biol Chem; 2012 Apr 13; 287(16):13228-38. PubMed ID: 22383527 [Abstract] [Full Text] [Related]
6. Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer. Velázquez-Vega LE, Rivera-Robles M, Sánchez-Álvarez AO, Vivas-Mejía PE, Aponte-Reyes M, Cruz-Collazo AM, Grafals-Ruiz N, Dorta-Estremera S, Hernández-O'Farrill E, Vlaar CP, Dharmawardhane S. Transl Oncol; 2024 Jun 13; 44():101928. PubMed ID: 38489873 [Abstract] [Full Text] [Related]
7. A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation, transformation, and migration. Guo X, Stafford LJ, Bryan B, Xia C, Ma W, Wu X, Liu D, Songyang Z, Liu M. J Biol Chem; 2003 Apr 11; 278(15):13207-15. PubMed ID: 12547822 [Abstract] [Full Text] [Related]
8. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer. Cruz-Collazo A, Ruiz-Calderon JF, Picon H, Borrero-Garcia LD, Lopez I, Castillo-Pichardo L, Del Mar Maldonado M, Duconge J, Medina JI, Bayro MJ, Hernández-O'Farrill E, Vlaar CP, Dharmawardhane S. Mol Cancer Ther; 2021 Dec 11; 20(12):2420-2432. PubMed ID: 34607932 [Abstract] [Full Text] [Related]
9. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Baugher PJ, Krishnamoorthy L, Price JE, Dharmawardhane SF. Breast Cancer Res; 2005 Dec 11; 7(6):R965-74. PubMed ID: 16280046 [Abstract] [Full Text] [Related]
10. The Cool-2/alpha-Pix protein mediates a Cdc42-Rac signaling cascade. Baird D, Feng Q, Cerione RA. Curr Biol; 2005 Jan 11; 15(1):1-10. PubMed ID: 15649357 [Abstract] [Full Text] [Related]
12. Targeting Cdc42 with the anticancer compound MBQ-167 inhibits cell polarity and growth in the budding yeast S. cerevisiae. Rivera-Robles MJ, Medina-Velázquez J, Asencio-Torres GM, González-Crespo S, Rymond BC, Rodríguez-Medina J, Dharmawardhane S. Small GTPases; 2020 Nov 01; 11(6):430-440. PubMed ID: 29969362 [Abstract] [Full Text] [Related]
13. Structural requirements for PAK activation by Rac GTPases. Knaus UG, Wang Y, Reilly AM, Warnock D, Jackson JH. J Biol Chem; 1998 Aug 21; 273(34):21512-8. PubMed ID: 9705280 [Abstract] [Full Text] [Related]
14. Targeting Rac and Cdc42 GEFs in Metastatic Cancer. Maldonado MDM, Medina JI, Velazquez L, Dharmawardhane S. Front Cell Dev Biol; 2020 Aug 21; 8():201. PubMed ID: 32322580 [Abstract] [Full Text] [Related]
15. Guanine nucleotide exchange factors regulate specificity of downstream signaling from Rac and Cdc42. Zhou K, Wang Y, Gorski JL, Nomura N, Collard J, Bokoch GM. J Biol Chem; 1998 Jul 03; 273(27):16782-6. PubMed ID: 9642235 [Abstract] [Full Text] [Related]
16. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells. Azios NG, Krishnamoorthy L, Harris M, Cubano LA, Cammer M, Dharmawardhane SF. Neoplasia; 2007 Feb 03; 9(2):147-58. PubMed ID: 17356711 [Abstract] [Full Text] [Related]
17. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells. Fortin SP, Ennis MJ, Schumacher CA, Zylstra-Diegel CR, Williams BO, Ross JT, Winkles JA, Loftus JC, Symons MH, Tran NL. Mol Cancer Res; 2012 Jul 03; 10(7):958-68. PubMed ID: 22571869 [Abstract] [Full Text] [Related]
18. Vav2 as a Rac-GDP/GTP exchange factor responsible for the nectin-induced, c-Src- and Cdc42-mediated activation of Rac. Kawakatsu T, Ogita H, Fukuhara T, Fukuyama T, Minami Y, Shimizu K, Takai Y. J Biol Chem; 2005 Feb 11; 280(6):4940-7. PubMed ID: 15485841 [Abstract] [Full Text] [Related]
19. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M, Williams MM, Hicks DJ, Jones B, Sanchez V, Young CD, Sarbassov DD, Muller WJ, Brantley-Sieders D, Cook RS. Breast Cancer Res; 2017 Jun 30; 19(1):74. PubMed ID: 28666462 [Abstract] [Full Text] [Related]
20. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Lim L, Manser E, Leung T, Hall C. Eur J Biochem; 1996 Dec 01; 242(2):171-85. PubMed ID: 8973630 [Abstract] [Full Text] [Related] Page: [Next] [New Search]